Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P08922
UPID:
ROS1_HUMAN
Alternative names:
Proto-oncogene c-Ros; Proto-oncogene c-Ros-1; Receptor tyrosine kinase c-ros oncogene 1; c-Ros receptor tyrosine kinase
Alternative UPACC:
P08922; Q15368; Q5TDB5
Background:
Proto-oncogene tyrosine-protein kinase ROS, known as c-Ros receptor tyrosine kinase, plays a pivotal role in epithelial cell differentiation and the regionalization of the proximal epididymal epithelium. It activates several signaling pathways, including the PI3 kinase-mTOR pathway, crucial for cell differentiation, proliferation, growth, and survival. It phosphorylates PTPN11, STAT3, VAV3, AKT1, MAPK1, MAPK3, IRS1, and PLCG2, mediating various cellular functions.
Therapeutic significance:
Understanding the role of Proto-oncogene tyrosine-protein kinase ROS could open doors to potential therapeutic strategies.